Astera has witnessed its success Pluvicto, or 177Lu-PSMA-617, is the first FDA-approved targeted radioligand therapy for PSMA+ metastatic, castration-resistant prostate cancer
Redifferentiation therapy with rosiglitazone in a case of differentiated thyroid cancer with pulmonary metastases and absence of radioiodine uptake
Benefits of PT-141 for Men For men, PT-141 can provide support in areas beyond traditional erectile medications
Whether used alone or in combination, these compounds each represent a distinct strategy in the evolving landscape of metabolic peptide science
Cardiovascular Health Benefits: Beyond just shedding pounds, Tirzepatide contributes to overall heart health, providing a more complete approach to metabolic well-being
Mold Exposure and Mycotoxins: A Unique Challenge Mycotoxins are toxic substances released by molds like Aspergillus, Penicillium, and Stachybotrys found in water-damaged buildings